Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Clinical trial NCT06515470 · RECRUITING
Trial details
- NCT number
- NCT06515470
- Sponsor
- Biotheryx, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-03
- Primary completion
- 2027-09-30
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.